亞普股份(603013.SH):2021年度擬新增不超4500萬美元額度範圍內的金融衍生品業務
格隆匯 3 月 24日丨亞普股份(603013.SH)公佈,2021年3月24日,公司第四屆董事會第六次會議和第四屆監事會第六次會議審議並通過了《關於公司2021年度預計開展金融衍生品業務的議案》。
因公司經營涉及進口業務,以外幣結算,為規避匯率風險,公司及納入合併範圍的子公司以實際國際業務為背景,2021年度擬新增不超過4500萬美元(含)額度範圍內的金融衍生品業務,利用外匯衍生交易的套期保值功能,對沖部分外幣結算時的匯率風險,降低匯率變動對經營的影響。操作的金融衍生品業務主要包括普通遠期產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.